PLoS ONE
(Jan 2012)
Correction: Rhodacyanine Derivative Selectively Targets Cancer Cells and Overcomes Tamoxifen Resistance.
- John Koren,
- Yoshinari Miyata,
- Janine Kiray,
- John C. O'Leary,
- Lana Nguyen,
- Jianping Guo,
- Laura J. Blair,
- Xiaokai Li,
- Umesh K. Jinwal,
- Jin Q. Cheng,
- Jason E. Gestwicki,
- Chad A. Dickey
Affiliations
- John Koren
- Yoshinari Miyata
- Janine Kiray
- John C. O'Leary
- Lana Nguyen
- Jianping Guo
- Laura J. Blair
- Xiaokai Li
- Umesh K. Jinwal
- Jin Q. Cheng
- Jason E. Gestwicki
- Chad A. Dickey
- DOI
-
https://doi.org/10.1371/annotation/7493e5d2-4c1a-43eb-a83f-16814861ff13
- Journal volume & issue
-
Vol. 7,
no. 7
WeChat QR code